Physician profile
Anuj Prasher
NPI 1073757183
$81,491.34
in general payments reported to CMS, 2019-2025
12 companies · $13K in 2025
The $13K reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,113 · 2021: $8,728 · 2022: $11K · 2023: $16K · 2024: $15K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $42K · Travel and Lodging: $1,094 · Consulting Fee: $450 · Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $41,836.60 |
| Travel and Lodging | $1,093.66 |
| Consulting Fee | $450.00 |
| Food and Beverage | $355.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $52,594.66 | 2019-2023 | Cohere, Tlif |
| Globus Medical, INC. | $27,801.35 | 2024-2025 | Cohere, Xlif, Excelsius Gps |
| Medtronic USA, INC. | $280.60 | 2019 | |
| Abbott Laboratories | $224.75 | 2019-2023 | Proclaim |
| Djo, LLC | $201.84 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $109.48 | 2021 | |
| Horizon Therapeutics Plc | $109.37 | 2019 | |
| Si-Bone, INC. | $56.81 | 2019-2022 | |
| Southern Edge Orthopaedics, INC. | $36.98 | 2023 | |
| Smith+Nephew, INC. | $31.21 | 2023 | Journey II |
| Medtronic, INC. | $28.17 | 2021-2024 | Aquamantys(Tm) |
| Pacira Pharmaceuticals Incorporated | $16.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Prasher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.